Combination meningitidis B/C vaccines

US8007815B1 · kind B1 · utility

Assignees

• Novartis AG · CH
• Statens Institutt for Folkehelse · NO

Inventors

• Dan M. Granoff · Berkeley, US
• Howard V. Raff · Mill Valley, US
• Ingeborg S. Aaberge · Oslo, NO
• Bjorn Haneberg · Oslo, NO
• Johan Holst · Oslo, NO

Key dates

• Filing date: May 28, 1999
• Grant date: Aug 30, 2011
• Expiry date: May 28, 2019

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S424/832
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Combination vaccines for treating or preventing Neisseria meningitidis infection are described. The vaccines include Neisseria meningitidis serogroup B proteoliposomic vesicles and Neissera meningitidis serogroup C conjugated oligosaccharides.